Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward K Geissler

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Cancer Treatment and Research|May 6, 2009
ImmunosuppressionEdward K Geissler
Transplantation Research|February 21, 2015
Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Edward K Geissler
Nature Reviews. Clinical Oncology|October 21, 2015
Post-transplantation malignancies: here today, gone tomorrow?Edward K Geissler
Transplantation Research|February 26, 2014
The influence of mTOR inhibitors on immunity and the relationship to post-transplant malignancyEdward K Geissler
Transplantation Direct|November 1, 2016
First Publication of Standardized Immune Monitoring Methods From the Virtual Global Transplantation Laboratory InitiativeEdward K Geissler
Transplantation Research|February 2, 2013
The ONE Study compares cell therapy products in organ transplantation: introduction to a review series on suppressive monocyte-derived cellsEdward K Geissler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2009
Rapamycin enhances lifespan: at last, an advantage for transplant recipients?Edward K Geissler
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 24, 2025
Is operational tolerance induction finally safe and feasible for some kidney transplant recipients: a breakthrough to a new horizon?Edward K Geissler, Birgit Sawitzki
Blood|July 23, 2011
Innovative blood vessels bring new lifeEdward K Geissler, Peter Angele
Transplantation Research|February 2, 2013
Open new possibilities in Transplantation ResearchEdward K Geissler, Alan Jardine
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Cancer Treatment and Research|May 6, 2009
ImmunosuppressionEdward K Geissler
Transplantation Research|February 21, 2015
Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Edward K Geissler
Nature Reviews. Clinical Oncology|October 21, 2015
Post-transplantation malignancies: here today, gone tomorrow?Edward K Geissler
Transplantation Research|February 26, 2014
The influence of mTOR inhibitors on immunity and the relationship to post-transplant malignancyEdward K Geissler
Transplantation Direct|November 1, 2016
First Publication of Standardized Immune Monitoring Methods From the Virtual Global Transplantation Laboratory InitiativeEdward K Geissler
Transplantation Research|February 2, 2013
The ONE Study compares cell therapy products in organ transplantation: introduction to a review series on suppressive monocyte-derived cellsEdward K Geissler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2009
Rapamycin enhances lifespan: at last, an advantage for transplant recipients?Edward K Geissler
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 24, 2025
Is operational tolerance induction finally safe and feasible for some kidney transplant recipients: a breakthrough to a new horizon?Edward K Geissler, Birgit Sawitzki
Blood|July 23, 2011
Innovative blood vessels bring new lifeEdward K Geissler, Peter Angele
Transplantation Research|February 2, 2013
Open new possibilities in Transplantation ResearchEdward K Geissler, Alan Jardine
Pageof 23